These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 13427964)

  • 1. [N-tolyl-sulfonyl-N'-butyl urea in the ambulatory therapy of diabetes].
    FRANCHI G
    Gazz Med Ital; 1957 Jan; 116(1):1-12. PubMed ID: 13427964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Oral therapy of diabetes mellitus by N-tolyl-sulfonyl-N'-butyl urea (D 860); clinical and experimental studies].
    BANDER A; CREUTZFELDT W; DORFMULLER T; EHRHART H; MARX R; MASKE H; MEIER W; MOHNIKE G; PFEIFFER EF; SCHLAGINTWEIT S; SCHOFFLING K; SCHOLZ J; SEIDLER I; STEIGERWALD H; STICH W; STOTTER G; ULRICH H
    Dtsch Med Wochenschr; 1956 May; 81(21):823-46; contd. PubMed ID: 13330473
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary note on the oral treatment of diabetes by N-sulfonyl-p-methylbenzene-N'-n-butyl urea or D 860, a product free of antibacterial action].
    MOREAU R; DEUIL R; SARRAZIN A; DE TRAVERSE PM; MARTINET M
    Presse Med (1893); 1956 Jul; 64(54):1261-4. PubMed ID: 13350129
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral treatment of diabetes mellitus with N-4-methyl-benzolsulfonyl-N'-butyl-urea (D-860); clinical and experimental research].
    Dtsch Med Wochenschr; 1956 Jun; 81(22):887-960; concl. PubMed ID: 13344014
    [No Abstract]   [Full Text] [Related]  

  • 5. The relation of various variables to the hypoglycemic action of 1-butyl-3-p-tolylsulfonylurea in patients with diabetes mellitus.
    DIENGOTT D; DOLGER H; MIRSKY IA
    Metabolism; 1956 Nov; 5(6 Part 2):875-93. PubMed ID: 13378057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oral treatment of diabetes mellitus with a sulfonamide derivative; N1-sulfanilyn-N2-n-butyl carbamide].
    ANGELI G; TEDESCHI G
    Minerva Med; 1956 Jun; 47(50):1968-75. PubMed ID: 13348337
    [No Abstract]   [Full Text] [Related]  

  • 7. [Infrared spectrography of N-sulfanilyl-N'-butyl urea & N-tolyl-sulfonyl-N'-butyl urea].
    PALA G
    Farmaco Sci; 1957; 12(4):255-67. PubMed ID: 13447979
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
    COLWELL AR; COLWELL JA
    Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
    [No Abstract]   [Full Text] [Related]  

  • 9. BZ 55 and D 860 in the treatment of diabetes mellitus.
    SCHNEIDER T; POLITZER WM
    S Afr Med J; 1957 Feb; 31(7):142-6. PubMed ID: 13409061
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophoretic serous patterns (proteins, lipoproteins and glycoproteins) of diabetics during treatment with N-sulfanilyl-N'-butyl urea and N-tolyl-sulfonyl-N'-butyl urea].
    ZAMPA GA
    G Clin Med; 1957 Jan; 38(1):42-57. PubMed ID: 13448420
    [No Abstract]   [Full Text] [Related]  

  • 11. CARBUTAMIDE and tolbutamide in diabetes.
    S Afr Med J; 1956 Dec; 30(51):1221-2. PubMed ID: 13391101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of diabetes with D 860].
    MOREAU R; DEUIL R; SARRAZIN A
    Gaz Med Fr; 1957 Mar; 64(6):527-42. PubMed ID: 13427959
    [No Abstract]   [Full Text] [Related]  

  • 13. [Trial of oral therapy in diabetes with D 860].
    DE TRAVERSE PM; DEUIL R; MOREAU R; SARRAZIN A
    Bull Mem Soc Med Hop Paris; 1956; 72(26):788-99. PubMed ID: 13383373
    [No Abstract]   [Full Text] [Related]  

  • 14. [Peroral treatment of diabetes. II. Oral treatment of diabetes mellitus with D 860].
    KUHLMANN F
    Med Klin; 1956 Nov; 51(45):1919-21. PubMed ID: 13386836
    [No Abstract]   [Full Text] [Related]  

  • 15. TOLBUTAMIDE in diabetes.
    Br Med J; 1957 Aug; 2(5040):343-5. PubMed ID: 13446477
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment for diabetes with sulfamide hypoglycemic agents].
    DEUIL R
    Rev Prat; 1956 Dec; 6(33):3687-94. PubMed ID: 13408836
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of diabetes mellitus with orinase; a preliminary report.
    BERGEMANN T; LEVITSKY LR; SUGAR SJ
    Med Ann Dist Columbia; 1956 Oct; 25(10):529-33; passim. PubMed ID: 13368760
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral hypoglycemic agents for treatment of diabetes mellitus.
    HACKEDORN HM
    Northwest Med; 1956 Sep; 55(9):965-7. PubMed ID: 13358973
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of diabetic patients; observations on the use of carbutamide and tolbutamide.
    BROWN FR; FRISKEY RW; GRINDLE L; KINSELL LW; SPLITTER S
    Calif Med; 1956 Nov; 85(5):285-8. PubMed ID: 13364673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orinase: its mode of action and use in the treatment of diabetes mellitus.
    HENRY WL; THOMAS RF; ALEXIS CP; KIM JH; HALL AS
    J Natl Med Assoc; 1957 May; 49(3):139-41. PubMed ID: 13429340
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.